Articles

Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation

Department of Pediatric Oncology, Hematology and Immunology, Children’s Hospital, University of Heidelberg, Germany;Molecular Medicine Partnership Unit, EMBL-University of Heidelberg, Germany;German Cancer Consortium (DKTK), Heidelberg, Germany
Molecular Medicine Partnership Unit, EMBL-University of Heidelberg, Germany;European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany;European Molecular Biology Laboratory (EMBL), Genomics Core Facility, Heidelberg, Germany
Department of Pediatric Oncology, Hematology and Immunology, Children’s Hospital, University of Heidelberg, Germany;Molecular Medicine Partnership Unit, EMBL-University of Heidelberg, Germany;German Cancer Consortium (DKTK), Heidelberg, Germany
Department of Pediatric Oncology, Hematology and Immunology, Children’s Hospital, University of Heidelberg, Germany;Molecular Medicine Partnership Unit, EMBL-University of Heidelberg, Germany
Department of Pediatric Oncology, Hematology and Immunology, Children’s Hospital, University of Heidelberg, Germany;Molecular Medicine Partnership Unit, EMBL-University of Heidelberg, Germany
Department of Pediatric Oncology, Hematology and Immunology, Children’s Hospital, University of Heidelberg, Germany;Molecular Medicine Partnership Unit, EMBL-University of Heidelberg, Germany
Division of Epigenomics and Cancer Risk Factors, The German Cancer Research Center (DKFZ), Heidelberg, Germany
Molecular Medicine Partnership Unit, EMBL-University of Heidelberg, Germany;European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany
Department of Pediatric Oncology/Hematology, Charité - Universitätsmedizin Berlin, Germany
Department of Pediatric Oncology/Hematology, Charité - Universitätsmedizin Berlin, Germany;German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
Department of Pediatric Oncology/Hematology, Charité - Universitätsmedizin Berlin, Germany
Department of Pediatric Oncology/Hematology, Charité - Universitätsmedizin Berlin, Germany
Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Germany
Department of Pediatric Hematology/Oncology, Medical School Hannover, Germany
Department of Human Genetics, University of Heidelberg, Germany
Molecular Oncology, Felsenstein Medical Research Center and Pediatric Hematology Oncology, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
Molecular Oncology, Felsenstein Medical Research Center and Pediatric Hematology Oncology, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
Children’s Hospital, University Hospital Tübingen, Germany
European Molecular Biology Laboratory (EMBL), Genomics Core Facility, Heidelberg, Germany
European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany
Molecular Medicine Partnership Unit, EMBL-University of Heidelberg, Germany;European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany
Department of Pediatric Oncology, Hematology and Immunology, Children’s Hospital, University of Heidelberg, Germany;Molecular Medicine Partnership Unit, EMBL-University of Heidelberg, Germany
Department of Pediatric Oncology, Hematology and Immunology, Children’s Hospital, University of Heidelberg, Germany;Molecular Medicine Partnership Unit, EMBL-University of Heidelberg, Germany;German Cancer Consortium (DKTK), Heidelberg, Germany
Vol. 100 No. 11 (2015): November, 2015 https://doi.org/10.3324/haematol.2015.129692